In July 2012, the US Food and Drug Administration approved the use of Truvada(TDF/FTC) for use as PrEP in HIV prevention in sexually active HIV–negative individuals. PrEP should be used in conjunction with other prevention methods to reduce the risk of infection.

Pre-Exposure Prophylaxis (PrEP) is a comprehensive HIV prevention strategy that involves the daily use of antiretroviral medications to reduce the risk of HIV infection in HIV-negative individuals. Starting on January 1st, 2018, WNCAP’s contract pharmacy will begin providing PrEP services to its clients and their families. 

For more information about PrEP visit the Centers for Disease Control and Prevention website.